X

Company profile for CeleCor Therapeutics

CeleCor Therapeutics

CELECOR THERAPEUTICS

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

Contact Supplier

Related Companies

Each year, more than 1.2 million Americans suffer a heart attack, one of the top three leading causes of death in the United States. PCI for serious heart attacks (ST-segment Elevated Myocardial Infarction or STEMI). PCI has greatly improved outcomes and emphasized the importance of initiating therapy as rapidly as possible, leading to major efforts to shorten the door to balloon time. Although the risk of dying of a heart a...

Each year, more than 1.2 million Americans suffer a heart attack, one of the top three leading causes of death in the United States. PCI for serious heart attacks (ST-segment Elevated Myocardial Infarction or STEMI). PCI has greatly improved outcomes and emphasized the importance of initiating therapy as rapidly as possible, leading to major efforts to shorten the door to balloon time. Although the risk of dying of a heart attack while in the hospital has decreased dramatically over the past four decades, pre-hospital treatment and subsequent mortality remains essentially unchanged.